Search

Your search keyword '"Louthrenoo, Worawit"' showing total 531 results
Start Over Author "Louthrenoo, Worawit"
531 results on '"Louthrenoo, Worawit"'

2. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study

Author

de Luca Montes, Ricardo Azêdo, Huq, Molla, Godfrey, Timothy, Oon, Shereen, Calderone, Alicia, Kandane-Rathnayake, Rangi, Louthrenoo, Worawit, Luo, Shue-Fen, Jan Wu, Yeong-Jian, Golder, Vera, Lateef, Aisha, Navarra, Sandra V., Zamora, Leonid, Hamijoyo, Laniyati, Sockalingam, Sargunan, An, Yuan, Li, Zhanguo, Katsumata, Yasuhiro, Harigai, Masayoshi, Chan, Madelynn, Goldblatt, Fiona, O’Neill, Sean, Lau, Chak Sing, Cho, Jiacai, Hoi, Alberta, Karyekar, Chetan S., Morand, Eric F., and Nikpour, Mandana

Published
2024
Full Text
View/download PDF

3. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

Author

Golder, Vera, Kandane-Rathnayake, Rangi, Li, Ning, Louthrenoo, Worawit, Chen, Yi-Hsing, Cho, Jiacai, Lateef, Aisha, Hamijoyo, Laniyati, Luo, Shue Fen, Wu, Yeong-Jian, Navarra, Sandra V, Zamora, Leonid, Li, Zhanguo, Sockalingam, Sargunan, Katsumata, Yasuhiro, Harigai, Masayoshi, Hao, Yanjie, Zhang, Zhuoli, Basnayake, Duminda, Chan, Madelynn, Kikuchi, Jun, Takeuchi, Tsutomu, Bae, Sang-Cheol, Goldblatt, Fiona, Oon, Shereen, O'Neill, Sean, Ng, Kristine, Law, Annie, Tugnet, Nicola, Kumar, Sunil, Tee, Cherica, Tee, Michael, Ohkubo, Naoaki, Tanaka, Yoshiya, Lau, Chak Sing, Hoi, Alberta, Nikpour, Mandana, and Morand, Eric F

Published
2024
Full Text
View/download PDF

7. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study

Author

Cho, Jiacai, Shen, Liang, Huq, Molla, Kandane-Rathnayake, Rangi, Golder, Vera, Louthrenoo, Worawit, Chen, Yi-Hsing, Hamijoyo, Laniyati, Luo, Shue-Fen, Wu, Yeong-Jian J, Zamora, Leonid, Li, Zhanguo, Sockalingam, Sargunan, Katsumata, Yasuhiro, Harigai, Masayoshi, Hao, Yanjie, Zhang, Zhuoli, Basnayake, Duminda, Chan, Madelynn, Kikuchi, Jun, Takeuchi, Tsutomu, Bae, Sang-Cheol, Oon, Shereen, O'Neill, Sean, Goldblatt, Fiona, Ng, Kristine Pek Ling, Law, Annie, Tugnet, Nicola, Kumar, Sunil, Tee, Cherica, Tee, Michael, Ohkubo, Naoaki, Tanaka, Yoshiya, Navarra, Sandra V, Lau, Chak Sing, Hoi, Alberta, Morand, Eric F, Nikpour, Mandana, and Lateef, Aisha

Published
2023
Full Text
View/download PDF

10. LSO-087 Sub-optimal use of anti-malarial therapy for SLE in the Asia Pacific region; observations from the Asia Pacific lupus cohort

Author

Tsutomu Takeuchi, Yoshiya Tanaka, Rangi Kandane-Rathnayake, Sang-Cheol Bae, Zhanguo Li, Shereen Oon, Vera Golder, Mandana Nikpour, Masayoshi Harigai, Yi-Hsing Chen, Zhuoli Zhang, Eric Morand, Chak Sing Lau, Sunil Kumar, Alberta Hoi, Sandra Navarra, Sean O’Neill, Michael Tee, Jun Kikuchi, Yanjie Hao, Shue Fen Luo, Yasuhiro Katsumata, Aisha Lateef, Laniyati Hamijoyo, Sargunan Sockalingam, Nicola Tugnet, Madelynn Chan, Jiacai Cho, Cherica Tee, Leonid Zamora, BMDB Basnayake, Fiona Goldblatt, Naoaki Ohkubo, Kristine (Pek Ling) Ng, Louthrenoo Worawit, Yeong-Jian Jan Wu, and Annie Hui Nee Law

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2023
Full Text
View/download PDF

13. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

Author

Bursill, David, Taylor, William J, Terkeltaub, Robert, Abhishek, Abhishek, So, Alexander K, Vargas-Santos, Ana Beatriz, Gaffo, Angelo Lino, Rosenthal, Ann, Tausche, Anne-Kathrin, Reginato, Anthony, Manger, Bernhard, Sciré, Carlo, Pineda, Carlos, van Durme, Caroline, Lin, Ching-Tsai, Yin, Congcong, Albert, Daniel Arthur, Biernat-Kaluza, Edyta, Roddy, Edward, Pascual, Eliseo, Becce, Fabio, Perez-Ruiz, Fernando, Sivera, Francisca, Lioté, Frédéric, Schett, Georg, Nuki, George, Filippou, Georgios, McCarthy, Geraldine, da Rocha Castelar Pinheiro, Geraldo, Ea, Hang-Korng, De Almeida Tupinambá, Helena, Yamanaka, Hisashi, Choi, Hyon K, Mackay, James, ODell, James R, Mellado, Janitzia Vázquez, Singh, Jasvinder A, Fitzgerald, John D, Jacobsson, Lennart TH, Joosten, Leo, Harrold, Leslie R, Stamp, Lisa, Andrés, Mariano, Gutierrez, Marwin, Kuwabara, Masanari, Dehlin, Mats, Janssen, Matthijs, Doherty, Michael, Hershfield, Michael S, Pillinger, Michael, Edwards, N Lawrence, Schlesinger, Naomi, Kumar, Nitin, Slot, Ole, Ottaviani, Sebastien, Richette, Pascal, MacMullan, Paul A, Chapman, Peter T, Lipsky, Peter E, Robinson, Philip, Khanna, Puja P, Gancheva, Rada N, Grainger, Rebecca, Johnson, Richard J, Kampe, Ritch Te, Keenan, Robert T, Tedeschi, Sara K, Kim, Seoyoung, Choi, Sung Jae, Fields, Theodore R, Bardin, Thomas, Uhlig, Till, Jansen, Tim, Merriman, Tony, Pascart, Tristan, Neogi, Tuhina, Klück, Viola, Louthrenoo, Worawit, and Dalbeth, Nicola

Subjects
Arthritis, Inflammatory and immune system, Consensus, Gout, Humans, Hyperuricemia, Terminology as Topic, gout, hyperuricemia, language, monosodium urate crystals, nomenclature, terminology, urate, Clinical Sciences, Immunology, Public Health and Health Services, Arthritis & Rheumatology
Abstract

ObjectiveThere is a lack of standardisation in the terminology used to describe gout. The aim of this project was to develop a consensus statement describing the recommended nomenclature for disease states of gout.MethodsA content analysis of gout-related articles from rheumatology and general internal medicine journals published over a 5-year period identified potential disease states and the labels commonly assigned to them. Based on these findings, experts in gout were invited to participate in a Delphi exercise and face-to-face consensus meeting to reach agreement on disease state labels and definitions.ResultsThe content analysis identified 13 unique disease states and a total of 63 unique labels. The Delphi exercise (n=76 respondents) and face-to-face meeting (n=35 attendees) established consensus agreement for eight disease state labels and definitions. The agreed labels were as follows: 'asymptomatic hyperuricaemia', 'asymptomatic monosodium urate crystal deposition', 'asymptomatic hyperuricaemia with monosodium urate crystal deposition', 'gout', 'tophaceous gout', 'erosive gout', 'first gout flare' and 'recurrent gout flares'. There was consensus agreement that the label 'gout' should be restricted to current or prior clinically evident disease caused by monosodium urate crystal deposition (gout flare, chronic gouty arthritis or subcutaneous tophus).ConclusionConsensus agreement has been established for the labels and definitions of eight gout disease states, including 'gout' itself. The Gout, Hyperuricaemia and Crystal-Associated Disease Network recommends the use of these labels when describing disease states of gout in research and clinical practice.

Published
2019

14. Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study

Author

Connelly, Kathryn, Kandane-Rathnayake, Rangi, Hoi, Alberta, Louthrenoo, Worawit, Hamijoyo, Laniyati, Cho, Jiacai, Lateef, Aisha, Fen Luo, Shue, Wu, Yeong-Jian J, Li, Zhanguo, Navarra, Sandra, Zamora, Leonid, Sockalingam, Sargunan, Hao, Yanjie, Zhang, Zhuoli, Katsumata, Yasuhiro, Harigai, Masayoshi, Oon, Shereen, Chan, Madelynn, Chen, Yi-Hsing, Bae, Sang-Cheol, O'Neill, Sean, Goldblatt, Fiona, Kikuchi, Jun, Takeuchi, Tsutomu, Ling Ng, Kristine Pek, Tugnet, Nicola, Basnayake, B M D B, Ohkubo, Naoaki, Tanaka, Yoshiya, Sing Lau, Chak, Nikpour, Mandana, Golder, Vera, and Morand, Eric F

Published
2022
Full Text
View/download PDF

15. Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

Author

Kandane-Rathnayake, Rangi, Golder, Vera, Louthrenoo, Worawit, Chen, Yi-Hsing, Cho, Jiacai, Lateef, Aisha, Hamijoyo, Laniyati, Luo, Shue-Fen, Wu, Yeong-Jian J, Navarra, Sandra V, Zamora, Leonid, Li, Zhanguo, Sockalingam, Sargunan, Katsumata, Yasuhiro, Harigai, Masayoshi, Hao, Yanjie, Zhang, Zhuoli, Basnayake, B M D B, Chan, Madelynn, Kikuchi, Jun, Takeuchi, Tsutomu, Bae, Sang-Cheol, Oon, Shereen, O'Neill, Sean, Goldblatt, Fiona, Ng, Kristine Pek Ling, Law, Annie, Tugnet, Nicola, Kumar, Sunil, Tee, Cherica, Tee, Michael, Ohkubo, Naoaki, Tanaka, Yoshiya, Yu, DaeYoung, Karyekar, Chetan S, Sing Lau, Chak, Monk, Julie A, Nikpour, Mandana, Hoi, Alberta, and Morand, Eric F

Published
2022
Full Text
View/download PDF

16. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study

Author

Appenzeller, Simone, Aranow, Cynthia, Askanase, Anca, Avcin, Tadej, Bae, Sang-Cheol, Bertsias, George, Bonfa, Eloisa, Cairoli, Ernesto, Cardiel, Mario H, Cervera, Ricard, Chasset, François, Chizzolini, Carlo, Clarke, Ann E, Conti, Fabrizio, Costedoat-Chalumeau, Nathalie, Czirják, László, Doria, Andrea, Dörner, Thomas, Espinosa, Gerard, Fischer-Betz, Rebecca, Garcìa, Mercedes, Gladman, Dafna D, González, Luis A, Gunnarsson, Iva, Hamijoyo, Laniyati, Hanly, John G, Hasni, Sarfaraz A, Houssiau, Frédéric A, Inanç, Murat, Inês, Luís S, Isenberg, David, Jacobsen, Soren, Jan Wu, Yeong-Jian, Kaneko, Yuko, Katsumata, Yasuhiro, Lau, Chak S, Legge, Alexandra C, Lerang, Karoline, Limper, Maarten, Louthrenoo, Worawit, Luo, Shue-Fen, Marinho, António, Massardo, Loreto, Mathian, Alexis, Mosca, Marta, Nikpour, Mandana, Pego-Reigosa, José M, Peschken, Christine A, Pons-Estel, Bernardo A, Pons-Estel, Guillermo J, Rahman, Anisur, Rednic, Simona, Ribi, Camillo, Ruiz-Irastorza, Guillermo, Sato, Emilia I, Saxena, Amit, Schneider, Matthias, Sebastiani, Gian Domenico, Strand, Vibeke, Svenungsson, Elisabet, Tanaka, Yoshiya, Tazi Mezalek, Zoubida, Tee, Michael L, Tincani, Angela, Touma, Zahi, Troldborg, Anne, Vasconcelos, Carlos, Vinet, Évelyne, Vital, Edward M, Voskuyl, Alexandre E, Voss, Anne, Wallace, Daniel, Ward, Michael, Zamora, Leonid D, Piga, Matteo, Chessa, Elisabetta, Morand, Eric F, Ugarte-Gil, Manuel F, Tektonidou, Maria, van Vollenhoven, Ronald, Petri, Michelle, and Arnaud, Laurent

Published
2022
Full Text
View/download PDF

17. ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study

Author

Kandane-Rathnayake, Rangi, Louthrenoo, Worawit, Hoi, Alberta, Luo, Shue-Fen, Wu, Yeong-Jian J., Chen, Yi-Hsing, Cho, Jiacai, Lateef, Aisha, Hamijoyo, Laniyati, Navarra, Sandra V., Zamora, Leonid, Sockalingam, Sargunan, An, Yuan, Li, Zhanguo, Katsumata, Yasuhiro, Harigai, Masayoshi, Hao, Yanjie, Zhang, Zhuoli, Kikuchi, Jun, Takeuchi, Tsutomu, Basnayake, B. M. D. B., Chan, Madelynn, Ng, Kristine Pek Ling, Tugnet, Nicola, Kumar, Sunil, Oon, Shereen, Goldblatt, Fiona, O’Neill, Sean, Gibson, Kathryn A., Ohkubo, Naoaki, Tanaka, Yoshiya, Bae, Sang-Cheol, Lau, Chak Sing, Nikpour, Mandana, Golder, Vera, and Morand, Eric F.

Published
2022
Full Text
View/download PDF

18. Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.

Author

Golder, Vera, Kandane-Rathnayake, Rangi, Louthrenoo, Worawit, Yi-Hsing Chen, Jiacai Cho, Lateef, Aisha, Laniyati Hamijoyo, Shue-Fen Luo, Wu, Yeong-Jian J., Navarra, Sandra V., Zamora, Leonid, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Basnayake, B. M. D. B., Madelynn Chan, and Jun Kikuchi

Published
2024
Full Text
View/download PDF

19. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.

Author

Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, Jiacai Cho, Louthrenoo, Worawit, Hoi, Alberta, Golder, Vera, Chak Sing Lau, Lateef, Aisha, Yi-Hsing Chen, Luo, Shue-Fen, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Zhanguo Li, Sockalingam, Sargunan, Navarra, Sandra, Zamora, Leonid, Yanjie Hao, Zhuoli Zhang, and Chan, Madelynn

Published
2024
Full Text
View/download PDF

20. Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

Author

Apostolopoulos, Diane, Kandane-Rathnayake, Rangi, Louthrenoo, Worawit, Luo, Shue Fen, Wu, Yeong-Jian, Lateef, Aisha, Golder, Vera, Sockalingam, Sargunan, Navarra, Sandra, Zamora, Leonid, Hamijoyo, Laniyati, Katsumata, Yasuhiro, Harigai, Masayoshi, Chan, Madelynn, O'Neill, Sean, Goldblatt, Fiona, Lau, Chak Sing, Li, Zhan Guo, Hoi, Alberta, Nikpour, Mandy, and Morand, Eric

Published
2020
Full Text
View/download PDF

22. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

Author

Katsumata, Yasuhiro, primary, Inoue, Eisuke, additional, Harigai, Masayoshi, additional, Cho, Jiacai, additional, Louthrenoo, Worawit, additional, Hoi, Alberta, additional, Golder, Vera, additional, Lau, Chak Sing, additional, Lateef, Aisha, additional, Chen, Yi-Hsing, additional, Luo, Shue-Fen, additional, Wu, Yeong-Jian Jan, additional, Hamijoyo, Laniyati, additional, Li, Zhanguo, additional, Sockalingam, Sargunan, additional, Navarra, Sandra, additional, Zamora, Leonid, additional, Hao, Yanjie, additional, Zhang, Zhuoli, additional, Chan, Madelynn, additional, Oon, Shereen, additional, Ng, Kristine, additional, Kikuchi, Jun, additional, Takeuchi, Tsutomu, additional, Goldblatt, Fiona, additional, O’Neill, Sean, additional, Tugnet, Nicola, additional, Law, Annie Hui Nee, additional, Bae, Sang-Cheol, additional, Tanaka, Yoshiya, additional, Ohkubo, Naoaki, additional, Kumar, Sunil, additional, Kandane-Rathnayake, Rangi, additional, Nikpour, Mandana, additional, and Morand, Eric F, additional

Published
2024
Full Text
View/download PDF

23. Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

Author

Golder, Vera, Kandane-Rathnayake, Rangi, Huq, Molla, Louthrenoo, Worawit, Luo, Shue Fen, Wu, Yeong-Jian Jan, Lateef, Aisha, Sockalingam, Sargunan, Navarra, Sandra V, Zamora, Leonid, Hamijoyo, Laniyati, Katsumata, Yasuhiro, Harigai, Masayoshi, Chan, Madelynn, O’Neill, Sean, Goldblatt, Fiona, Lau, Chak Sing, Li, Zhan Guo, Hoi, Alberta, Nikpour, Mandana, and Morand, Eric F

Published
2019
Full Text
View/download PDF

24. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

Author

Golder, Vera, Kandane-Rathnayake, Rangi, Huq, Molla, Nim, Hieu T, Louthrenoo, Worawit, Luo, Shue Fen, Wu, Yeong-Jian Jan, Lateef, Aisha, Sockalingam, Sargunan, Navarra, Sandra V, Zamora, Leonid, Hamijoyo, Laniyati, Katsumata, Yasuhiro, Harigai, Masayoshi, Chan, Madelynn, O'Neill, Sean, Goldblatt, Fiona, Lau, Chak Sing, Li, Zhan Guo, Hoi, Alberta, Nikpour, Mandana, and Morand, Eric F

Published
2019
Full Text
View/download PDF

26. HLA Association among Thai Patients with Diffuse and Limited Cutaneous Systemic Sclerosis.

Author

Louthrenoo, Worawit, Kasitanon, Nuntana, Wongthanee, Antika, Okudaira, Yuko, Takeuchi, Asuka, Noguchi, Hiroshi, Inoko, Hidetoshi, and Takeuchi, Fujio

Subjects
THAI people, SYSTEMIC scleroderma, HAPLOTYPES
Abstract

This study aimed to clarify the association of HLA Class I and II with dcSSc and lcSSc in Thais. HLA typing for 11 gene loci (Class I: HLA-A, B and C, and Class II [HLA-DR, DP and DQ]) was carried out using the Next Generation DNA Sequencing method (three fields) in 92 Thai patients with systemic sclerosis (55 dcSSc, 37 lcSSc) and 135 healthy controls (HCs). The distribution of HLA alleles in patients with dcSSc and lcSSc was compared. When compared with HCs, the AF of A*24:02:01, A*24:07:01, B*27:04:01 and B*27:06 showed an increasing trend in lcSSc patients without statistical significance. DRB1*15:02:01, DRB5*01:02:01, DQA1*01:01:01, DQB1*05:01:24, DPA1*02:01:01 and DPB1*13:01:01 increased significantly in dcSSc patients. DQB1*05:01:24 and DPB1*13:01:01 also increased significantly in lcSSc patients, but less significantly than in dcSSc patients. The association of DPB1*05:01:01 with lcSSc was significantly protective. HLA-A*24:02:01, B*27:06 and C*03:04:01 formed a three-locus haplotype that also constituted an eight-locus haplotype with DRB1*15:02:01, DQA1*01:01:01, DQB1*05:01:24, DPA1*02:01:01 and DPB1*13:01:01. There was a possibility that HLA Class I would play a role in the pathogenesis of lcSSc, while Class II played more of a role in the dcSSc in Thai patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Prevalence of thyroid dysfunctions and thyroid autoantibodies in Thai patients with systemic lupus erythematosus: An age‐ and sex‐matched controlled study.

Author

Na‐Nan, Kittiya, Waisayanand, Nipawan, Gumtorntip, Wanitcha, Wongthanee, Antika, Kasitanon, Nuntana, and Louthrenoo, Worawit

Subjects
SYSTEMIC lupus erythematosus, THAI people, THYROID diseases, THYROID cancer, AUTOANTIBODIES, THYROID gland function tests, FAMILY history (Medicine)
Abstract

Background/Objective: To determine the prevalence of thyroid dysfunctions and thyroid autoantibodies in Thai systemic lupus erythematosus (SLE) patients, and compare them with age‐ and sex‐matched healthy controls (HCs). Associations between thyroid dysfunctions and SLE disease activity, and associated factors for thyroid dysfunctions in SLE also were determined. Method: One hundred SLE patients, without apparent clinical thyroid disease, attended the Rheumatology Clinic between November 2021 and October 2022, were enrolled into this study. HCs were matched to SLE cases by age and sex (ratio of 1:1). Clinical manifestations, SLE disease activity and medication received were collected in all SLE patients. Thyroid function tests and thyroid autoantibodies (anti‐thyroglobulin: anti‐TG and anti‐thyroid peroxidase: anti‐TPO) were collected from all participants. Results: When compared with HCs, SLE patients had higher prevalence of thyroid dysfunctions, hypothyroidism and euthyroid sick syndrome (28% vs. 7%, p <.001, and 12% vs. 2%, p =.010, and 6% vs. 0%, p =.013, respectively). Prevalence of isolated hypothyroxinemia was higher numerically in SLE patients (9% vs. 3%, p =.074). Prevalence of anti‐TG or anti‐TPO was no different between SLE patients and HCs (16% vs. 18%, p =.707). There was no association between SLE disease activity and abnormal thyroid functions or thyroid autoantibodies. Family history of thyroid disease and prednisolone use (>10 mg/day) were associated factors for thyroid abnormalities with adjusted OR (95% CI) of 6.13 (1.58–23.75), p =.009 and 4.00 (1.37–11.70), p =.011, respectively. Conclusion: Thyroid dysfunctions were more prevalent in SLE patients. Family history of thyroid disease and prednisolone use (>10 mg/day) were independent associated factors of thyroid abnormalities. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Safety and effectiveness of intravenous CT-P13 in inflammatory arthritis: post-marketing surveillance study in Thailand

Author

Mahakkanukrauh, Ajanee, primary, Chaiamnuay, Sumapa, additional, Koolvisoot, Ajchara, additional, Kitamnuayphong, Tassanee, additional, Manavathongchai, Siriporn, additional, Osiri, Manathip, additional, Louthrenoo, Worawit, additional, Uea-areewongsa, Parichat, additional, Ahn, Keumyoung, additional, Jung, Nahyun, additional, Kim, Minkyung, additional, Lee, Seulgi, additional, Kim, Hanna, additional, and Kim, Sunghyun, additional

Published
2023
Full Text
View/download PDF

30. LSO-036 Cluster analysis and subphenotype stratification in lupus erythematosus based on data from the Asia Pacific lupus collaboration cohort (APLC-CASTLE)

Author

Wai Chan, Shirley Chiu, primary, Louthrenoo, Worawit, additional, Hoi, Alberta, additional, Luo, Shue Fen, additional, Wu, Yeong-Jian Jan, additional, Chen, Yi-Hsing, additional, Cho, Jiacai, additional, Lateef, Aisha, additional, Hamijoyo, Laniyati, additional, Navarra, Sandra, additional, Zamora, Leonid, additional, Sockalingam, Sargunan, additional, An, Yuan, additional, Li, Zhanguo, additional, Katsumata, Yasuhiro, additional, Harigai, Masayoshi, additional, Hao, Yanjie, additional, Zhang, Zhuoli, additional, Kikuchi, Jun, additional, Takeuchi, Tsutomu, additional, Basnayake, BMDB, additional, Chan, Madelynn, additional, Ng, Kristine, additional, Tugnet, Nicola, additional, Kumar, Sunil, additional, Oon, Shereen, additional, Goldblatt, Fiona, additional, O’Neill, Sean, additional, Gibson, Kathryn, additional, Ohkubo, Naoaki, additional, Tanaka, Yoshiya, additional, Bae, Sang-Cheol, additional, Kandane-Rathnayake, Rangi, additional, Nikpour, Mandana, additional, Golder, Vera, additional, Morand, Eric, additional, and Lau, Chak Sing, additional

Published
2023
Full Text
View/download PDF

31. LSO-031 Association of serologic and clinical low disease activity states with outcomes in a large multi-national lupus cohort

Author

Hao, Yanjie, primary, Oon, Shereen, additional, Li, Ning, additional, Louthrenoo, Worawit, additional, Chen, Yi-Hsing, additional, Cho, Jiacai, additional, Lateef, Aisha, additional, Hamijoyo, Laniyati, additional, Luo, Shue Fen, additional, Wu, Yeong-Jian, additional, Navarra, Sandra, additional, Zamora, Leonid, additional, Li, Zhanguo, additional, An, Yuan, additional, Sockalingam, Sargunan, additional, Katsumata, Yasuhiro, additional, Harigai, Masayoshi, additional, Zhang, Zhuoli, additional, Chan, Madelynn, additional, Kikuchi, Jun, additional, Takeuchi, Tsutomu, additional, Bae, Sang-Cheol, additional, Goldblatt, Fiona, additional, O’Neill, Sean, additional, Ng, Kristine, additional, Law, Annie, additional, Basnayake, Duminda, additional, Tugnet, Nicola, additional, Kumar, Sunil, additional, Tee, Michael, additional, Tee, Cherica, additional, Tanaka, Yoshiya, additional, Lau, CS, additional, Golder, Vera, additional, Hoi, Alberta, additional, Kandane-Rathnayake, Rangi, additional, Morand, Eric, additional, and Nikpour, Mandana, additional

Published
2023
Full Text
View/download PDF

32. LO-004 Frequency and determinants of flare and persistently active disease in a large multinational prospective lupus cohort

Author

Hao, Yanjie, primary, Kandane-Rathnayake, Rangi, additional, Li, Ning, additional, Louthrenoo, Worawit, additional, Chen, Yi-Hsing, additional, Cho, Jiacai, additional, Lateef, Aisha, additional, Hamijoyo, Laniyati, additional, Luo, Shue Fen, additional, Wu, Yeong-Jian, additional, Navarra, Sandra, additional, Zamora, Leonid, additional, Li, Zhanguo, additional, An, Yuan, additional, Sockalingam, Sargunan, additional, Katsumata, Yasuhiro, additional, Harigai, Masayoshi, additional, Zhang, Zhuoli, additional, Chan, Madelynn, additional, Kikuchi, Jun, additional, Takeuchi, Tsutomu, additional, Bae, Sang-Cheol, additional, Goldblatt, Fiona, additional, O’Neill, Sean, additional, Ng, Kristine, additional, Law, Annie, additional, Basnayake, Duminda, additional, Tugnet, Nicola, additional, Kumar, Sunil, additional, Tee, Michael, additional, Tee, Cherica, additional, Tanaka, Yoshiya, additional, Lau, CS, additional, Golder, Vera, additional, Hoi, Alberta, additional, Morand, Eric, additional, Oon, Shereen, additional, and Nikpour, Mandana, additional

Published
2023
Full Text
View/download PDF

33. LSO-080 Machine-learning approach on lupus low disease activity prediction

Author

Faelnar, Nick, primary, Tee, Michael, additional, Tee, Cherica, additional, Caro, Jaime, additional, Solano, Geoffrey, additional, Kandane-Rathnayake, Rangi, additional, Magbitang-Santiago, Angelene Therese, additional, Salido, Evelyn, additional, Golder, Vera, additional, Louthrenoo, Worawit, additional, Chen, Yi-Hsing, additional, Cho, Jiacai, additional, Lateef, Aisha, additional, Hamijoyo, Laniyati, additional, Luo, Shue-Fen, additional, Wu, Yeong-Jian J, additional, Navarra, Sandra, additional, Zamora, Leonid, additional, Li, Zhanguo, additional, Sockalingam, Sargunan, additional, Katsumata, Yasuhiro, additional, Harigai, Masayoshi, additional, Hao, Yanjie, additional, Zhang, Zhuoli, additional, Basnayake, BMDB, additional, Chann, Madelynn, additional, Kikuchi, Jun, additional, Takeuchi, Tsutomu, additional, Bae, Sang-Cheol, additional, Oon, Shereen, additional, O’Neill, Sean, additional, Goldblatt, Fiona, additional, Ng, Kristine, additional, Law, Annie, additional, Tugnet, Nicola, additional, Kumar, Sunil, additional, Ohkubo, Naoaki, additional, Tanaka, Yoshiya, additional, Lau, Chak Sing, additional, Nikpour, Mandana, additional, Hoi, Alberta, additional, and Morand, Eric, additional

Published
2023
Full Text
View/download PDF

35. SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus—an analysis of anti-double-stranded DNA monitoring.

Author

Yeo, Ai Li, Kandane-Rathnayake, Rangi, Koelmeyer, Rachel, Golder, Vera, Louthrenoo, Worawit, Chen, Yi-Hsing, Cho, Jiacai, Lateef, Aisha, Hamijoyo, Laniyati, Luo, Shue-Fen, Wu, Yeong-Jian J, Navarra, Sandra V, Zamora, Leonid, Li, Zhanguo, An, Yuan, Sockalingam, Sargunan, Katsumata, Yasuhiro, Harigai, Masayoshi, Hao, Yanjie, and Zhang, Zhuoli

Subjects
SYSTEMIC lupus erythematosus diagnosis, KRUSKAL-Wallis Test, DNA, CONFIDENCE intervals, ACQUISITION of data, LONGITUDINAL ligaments, RESEARCH funding, CHI-squared test, DESCRIPTIVE statistics, BLOOD testing, LONGITUDINAL method
Abstract

Objective Disease activity monitoring in SLE includes serial measurement of anti-double stranded-DNA (dsDNA) antibodies, but in patients who are persistently anti-dsDNA positive, the utility of repeated measurement is unclear. We investigated the usefulness of serial anti-dsDNA testing in predicting flare in SLE patients who are persistently anti-dsDNA positive. Methods Data were analysed from patients in a multinational longitudinal cohort with known anti-dsDNA results from 2013 to 2021. Patients were categorized based on their anti-dsDNA results as persistently negative, fluctuating or persistently positive. Cox regression models were used to examine longitudinal associations of anti-dsDNA results with flare. Results Data from 37 582 visits of 3484 patients were analysed. Of the patients 1029 (29.5%) had persistently positive anti-dsDNA and 1195 (34.3%) had fluctuating results. Anti-dsDNA expressed as a ratio to the normal cut-off was associated with the risk of subsequent flare, including in the persistently positive cohort (adjusted hazard ratio [HR] 1.56; 95% CI: 1.30, 1.87; P  < 0.001) and fluctuating cohort (adjusted HR 1.46; 95% CI: 1.28, 1.66), both for a ratio >3. Both increases and decreases in anti-dsDNA more than 2-fold compared with the previous visit were associated with increased risk of flare in the fluctuating cohort (adjusted HR 1.33; 95% CI: 1.08, 1.65; P  = 0.008) and the persistently positive cohort (adjusted HR 1.36; 95% CI: 1.08, 1.71; P  = 0.009). Conclusion Absolute value and change in anti-dsDNA titres predict flares, including in persistently anti-dsDNA positive patients. This indicates that repeat monitoring of dsDNA has value in routine testing. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. Non‐loading versus loading low‐dose colchicine in acute crystal‐associated arthritis: A double‐blinded randomized controlled study.

Author

Laosuksri, Ployrung, Phrintrakul, Nathrudee, Gumtorntip, Wanitcha, Na‐Nan, Kittiya, Wongthanee, Antika, Kasitanon, Nuntana, and Louthrenoo, Worawit

Subjects
ARTHRITIS, COLCHICINE, KIDNEY physiology, PAIN management, UNIVERSITY hospitals
Abstract

Introduction: This study aimed to compare the efficacy of non‐loading versus loading low‐dose colchicine in patients with acute crystal‐associated arthritis. Materials and Methods: All in‐patients who were admitted to Chiang Mai University Hospital with non‐arthritis disease and developed acute crystal‐associated arthritis during admission (within 48 h after arthritis onset) were invited to join this study. The patients were randomized into two groups. Patients in Group I (non‐loading group) and Group II (loading group) received colchicine at 1.2 and 2.4 mg in the first 24 h, respectively. The primary outcome was the patients' pain response at 24 h after treatment. Results: Of 80 patients, 49 were acute gouty arthritis, and 31 acute calcium pyrophosphate (CPP) arthritis. The mean [95% CI] pain score was no different between Groups I and II at the baseline level (6.46[5.72–7.19] vs. 6.654[5.85–7.44], p =.867) and at 24 h (3.13[2.43–3.82] vs. 3.18[2.42–3.93], p =.907). The proportion of patients with ≥50% pain reduction was not different (57.50% vs. 55.00%, p =.822). Sensitivity analysis among patients with a baseline pain score of ≥4 showed the same pattern of response. Mild diarrhea was common and comparable in both groups. Subgroup analysis according to renal function (eGFR < 60 vs. ≥60 mL/min/1.73 m2) or type of crystals (acute gouty arthritis vs. acute CPP arthritis) also showed the same pattern of response. Conclusion: Non‐loading low‐dose colchicine was as effective as loading low‐dose colchicine in patients with acute crystal‐associated arthritis, regardless of renal function or type of crystals. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

43. Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey

Author

Ramos-Remus, Cesar, Ramirez-Gomez, Andrea, Brambila-Barba, Victor, Barajas-Ochoa, Aldo, Castillo-Ortiz, Jose D., Adebajo, Adewale O., Espinoza, Luis R., Aceves-Avila, Francisco J., Sánchez-González, Jorge M., Boudersa, Nadia, Slimani, Samy, Ladjouze-Rezig, Aicha, Diaz, Mónica P., Kirmayr, Karin I., Asnal, Cecilia A., Catoggio, Luis J., Citera, Gustavo, Casado, Gustavo C., Alvarez, Analia P., Pisoni, Cecilia N., Benavente, Emilio, Lopez-Cabanillas, Adriana, Baez, Roberto M., Pons-Estel, Bernardo A., Sacnún, Mónica P., Cavallasca, Javier A., Paniego, Raúl H., Proudman, Susanna M., Thomas, Ranjeny, Major, Gabor, Mathers, David M., Schrieber, Leslie, Haq, Syed A., Islam, Nazrul, Dessein, Patrick H., von Muhlen, Carlos A., Bianchi, Washington A., da R. Castelar-Pinheiro, Geraldo, Feldman-Pollak, Daniel, Cossermelli, Waldenise, Bonfiglioli, Karina R., Giorgi, Rina D., Zabsonre-Tiendrebeogo, Wendlassida J., Russell, Anthony S., Olaru, Lilia, Karsh, Jacob, Fuentealba, Carlos, Aguilera, Sergio, Castro-Esparza, Irene H., Burgos, Paula I., Neira, Oscar, Li, Zhan-guo, Tam, Lai-Shan, Mok, Mo Y., Medina, Yimy F., Moreno-Alvarez, Mario J., Zúñiga-Vera, Andrés E., Vera, Claudia, Quezada, Ivonne, Moreno, Iván M., Calapaqui, Wendy, El-Mardenly, Ghada, Salama, M. Salah, Ragab, Gaafar, Hadidi, Tahsin, Gado, Kamel, Leirisalo-Repo, Marjatta, Tuompo, Riitta, Koivuniemi, Riitta, Berenbaum, Francis, Allanore, Yannick, Constantin, Arnaud, Buttgereit, Frank, Schulze-Koops, Hendrik, Liz, Myriam, Dey, Dzifa, Alonzo-Borjas, Hugo D., Santiago-Pastelín, Carlos B., Cuéllar-Cruz, Víctor, Dharmanand, Balebail G., Yathish, G. C., Akerkar, Shashank M., Malaviya, Anand N., Ahmadzadeh, Arman, Hasunuma, Tomoko, Owino, Benard O., Pacheco-Tena, César, Frausto-Arenas, Aaron, De la Madrid-Cernas, Adrián A., Cardona-Cabrera, Román, Centeno-Valadez, Juan D., Rodríguez-Torres, Isaura M., Vaidya, Binit, Gupta, Arun K., Harrison, Andrew A., Grainger, Rebecca, Nwankwo, Henry M., Diamantopoulos, Andreas P., Mæland, Elisabeth, Besada, Emilio, Gorriz, Luis, Duarte, Margarita, Albrecht, Maria T. Romero-de, Cabrera-Villalba, Sonia, Segami, María I., García-Poma, Augusto, Pérez-Medina, Wilkerson, Ramos, María P., Navarra, Sandra V., Racaza, Geraldine Z., Penserga, Ester G., Manapat-Reyes, Bernadette H., Dianongco, Maria L., Lichauco, Juan J., Torralba, Tito P., Al-Emadi, Samar, Hammoudeh, Mohammed, Botchkova, Anna G., AlSaeedi, Sabri H., Almoallim, Hani, Al-Arfaj, Hussein F., Koh, Wei H., Leung, Ying Y., Whitelaw, David A., Hodkinson, Bridget, García-Miguel, Javier, Duro, Juan C., Andreu, José L., Martin-Mola, Emilio, Ahijón-Lana, María, Finckh, Axel, Alpízar-Rodríguez, Deshiré, Osiri, Manathip, Kasitanon, Nuntana, Louthrenoo, Worawit, de Vries, Niek, van Denderen, Christiaan, Gerritsen, Martjin, van Vollenhoven, Ronald F., Jansen, Tim L., van Riel, Piet, Núñez-Sotelo, Concepción M., Villegas-Morales, Sol, and GEO-RA Group

Published
2017
Full Text
View/download PDF

44. Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study

Author

Connelly, Kathryn, primary, Kandane‐Rathnayake, Rangi, additional, Hoi, Alberta, additional, Louthrenoo, Worawit, additional, Hamijoyo, Laniyati, additional, Luo, Shue Fen, additional, Wu, Yeong‐Jian Jan, additional, Cho, Jiacai, additional, Lateef, Aisha, additional, Lau, CS, additional, Chen, Yi‐Hsing, additional, Navarra, Sandra, additional, Zamora, Leonid, additional, Li, Zhanguo, additional, An, Yuan, additional, Sockalingam, Sargunan, additional, Hao, Yanjie, additional, Zhang, Zhuoli, additional, Chan, Madelynn, additional, Katsumata, Yasuhiro, additional, Harigai, Masayoshi, additional, Oon, Shereen, additional, Bae, Sang‐Cheol, additional, O'Neill, Sean, additional, Gibson, Kathryn A., additional, Basnayake, BMDB, additional, Kikuchi, Jun, additional, Takeuchi, Tsutomu, additional, Ng, Kristine Pek Ling, additional, Tugnet, Nicola, additional, Kumar, Sunil, additional, Goldblatt, Fiona, additional, Law, Annie, additional, Tee, Michael, additional, Tee, Cherica, additional, Tanaka, Yoshiya, additional, Ohkubo, Naoaki, additional, Tan, Jin Yu, additional, Karyekar, Chetan S., additional, Nikpour, Mandana, additional, Golder, Vera, additional, and Morand, Eric F., additional

Published
2022
Full Text
View/download PDF

45. Brief Report: Validation of a Definition of Flare in Patients With Established Gout

Author

Gaffo, Angelo L., Dalbeth, Nicola, Saag, Kenneth G., Singh, Jasvinder A., Rahn, Elizabeth J., Mudano, Amy S., Chen, Yi‐Hsing, Lin, Ching‐Tsai, Bourke, Sandra, Louthrenoo, Worawit, Vazquez‐Mellado, Janitzia, Hernández‐Llinas, Hansel, Neogi, Tuhina, Vargas‐Santos, Ana Beatriz, da Rocha Castelar‐Pinheiro, Geraldo, Amorim, Rodrigo B. C., Uhlig, Till, Hammer, Hilde B., Eliseev, Maxim, Perez‐Ruiz, Fernando, Cavagna, Lorenzo, McCarthy, Geraldine M., Stamp, Lisa K., Gerritsen, Martijn, Fana, Viktoria, Sivera, Francisca, and Taylor, William

Published
2018
Full Text
View/download PDF

50. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus:the PISCOS study

Author

Piga, Matteo, Chessa, Elisabetta, Morand, Eric F., Ugarte-Gil, Manuel F., Tektonidou, Maria, van Vollenhoven, Ronald, Petri, Michelle, Arnaud, Laurent, Appenzeller, Simone, Aranow, Cynthia, Askanase, Anca, Avcin, Tadej, Bae, Sang Cheol, Bertsias, George, Bonfa, Eloisa, Cairoli, Ernesto, Cardiel, Mario H., Cervera, Ricard, Chasset, François, Chizzolini, Carlo, Clarke, Ann E., Conti, Fabrizio, Costedoat-Chalumeau, Nathalie, Czirják, László, Doria, Andrea, Dörner, Thomas, Espinosa, Gerard, Fischer-Betz, Rebecca, Garcìa, Mercedes, Gladman, Dafna D., González, Luis A., Gunnarsson, Iva, Hamijoyo, Laniyati, Hanly, John G., Hasni, Sarfaraz A., Houssiau, Frédéric A., Inanç, Murat, Inês, Luís S., Isenberg, David, Jacobsen, Soren, Jan Wu, Yeong Jian, Kaneko, Yuko, Katsumata, Yasuhiro, Lau, Chak S., Legge, Alexandra C., Lerang, Karoline, Limper, Maarten, Louthrenoo, Worawit, Luo, Shue Fen, Marinho, António, Piga, Matteo, Chessa, Elisabetta, Morand, Eric F., Ugarte-Gil, Manuel F., Tektonidou, Maria, van Vollenhoven, Ronald, Petri, Michelle, Arnaud, Laurent, Appenzeller, Simone, Aranow, Cynthia, Askanase, Anca, Avcin, Tadej, Bae, Sang Cheol, Bertsias, George, Bonfa, Eloisa, Cairoli, Ernesto, Cardiel, Mario H., Cervera, Ricard, Chasset, François, Chizzolini, Carlo, Clarke, Ann E., Conti, Fabrizio, Costedoat-Chalumeau, Nathalie, Czirják, László, Doria, Andrea, Dörner, Thomas, Espinosa, Gerard, Fischer-Betz, Rebecca, Garcìa, Mercedes, Gladman, Dafna D., González, Luis A., Gunnarsson, Iva, Hamijoyo, Laniyati, Hanly, John G., Hasni, Sarfaraz A., Houssiau, Frédéric A., Inanç, Murat, Inês, Luís S., Isenberg, David, Jacobsen, Soren, Jan Wu, Yeong Jian, Kaneko, Yuko, Katsumata, Yasuhiro, Lau, Chak S., Legge, Alexandra C., Lerang, Karoline, Limper, Maarten, Louthrenoo, Worawit, Luo, Shue Fen, and Marinho, António

Abstract

The Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus (PISCOS) study aimed to obtain an evidence-based and expert-based consensus standardisation of the Physician Global Assessment (PGA) scoring of disease activity in systemic lupus erythematosus (SLE). An international panel of 79 SLE experts participated in a three-round Delphi consensus process, in which 41 statements related to the PGA in SLE were rated, using a 0 (strongly disagree) to 10 (strongly agree) numerical rating scale. Statements with agreement of 75% or greater were selected and further validated by the expert panel. Consensus was reached on 27 statements, grouped in 14 recommendations, for the use of the PGA in SLE, design of the PGA scale, practical considerations for PGA scoring, and the relationship between PGA values and levels of disease activity. Among these recommendations, the expert panel agreed that the PGA should consist of a 0–3 visual analogue scale for measuring disease activity in patients with SLE in the preceding month. The PGA is intended to rate the overall disease activity, taking into account the severity of active manifestations and clinical laboratory results, but excluding organ damage, serology, and subjective findings unrelated to disease activity. The PGA scale ranges from “no disease activity” (0) to the “most severe disease activity” (3) and incorporates the values 1 and 2 as inner markers to categorise disease activity as mild (≥0·5 to 1), moderate (>1 and ≤2) and severe (>2 to 3). Only experienced physicians can rate the PGA, and it should be preferably scored by the same rater at each visit. The PISCOS results will allow for increased homogeneity and reliability of PGA ratings in routine clinical practice, definitions of remission and low disease activity, and future SLE trials.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results